Lumedica Receives Phase II SBIR-NSF Grant to develop dual-axis optical coherence tomography for deep tissue imaging.
DURHAM, NORTH CAROLINA — Lumedica Inc., a privately held company, [...]
OCT-Based Imaging Technology Detects Alzheimer’s in Mice
Lumedica founder and Chief Executive, Dr. Adam Wax continues to [...]
Fun with OCT at Home
While some of us are using this "shelter at home" [...]
Virtual Skin Biopsy Device in the Works
When you make a great imaging technology more affordable, more [...]
Affordable OCT is Key in Promising New Cartilage Study Technique
The American Association for the Advancement of Science recognized the [...]
Lumedica Receives $1M Phase II NIH-SBIR Grant, in Support of Detecting Eye Disease Around the World.
DURHAM, NORTH CAROLINA - Lumedica Inc., a privately held company, [...]
Dr. Adam Wax Publishes Results of First Clinical Study of Low-Cost Retinal OCT
We've known since Lumedica's founding that the low-cost OCT would [...]
Retinal Division of Lumedica Awarded $250K in 2019 Luminate Accelerator Program
The Upstate New York economic development program, "Luminate," which helps [...]
New Approach to Skin Cancer Detection Driven by Affordable OCT
Dr. Fred Silver, Professor of Pathology at Robert Wood Johnson [...]
Lumedica Debuts Labscope 2.0
Lumedica launched its newest product at SPIE's BIOS / Photonics [...]